Rakesh Kumar

发表

Stimulation of Inducible Nitric Oxide by Hepatitis B Virus Transactivator Protein HBx Requires MTA1 Coregulator*

F. Murad, Rakesh Kumar, S. Pakala, 2009, The Journal of Biological Chemistry.

SHP-1 Regulates Lck-induced Phosphatidylinositol 3-Kinase Phosphorylation and Activity*

Yiling Lu, K. Siminovitch, Yiling Lu, 1999, The Journal of Biological Chemistry.

Interferon-induces expression of cyclin-dependent kinase-inhibitors p21WAF1 and p27Kip1 that prevent activation of cyclin-dependent kinase by CDK-activating kinase (CAK)

Mahitosh Mandal, M. Mandal, Rakesh Kumar, 1998, Oncogene.

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Ming-Chih Crouthamel, L. Harrington, T. Gilmer, 2007, Molecular Cancer Therapeutics.

MicroRNA-661, a c/EBPalpha target, inhibits metastatic tumor antigen 1 and regulates its functions.

K. Ohshiro, Rakesh Kumar, S. Rayala, 2009, Cancer research.

Ciz1, a Novel DNA-binding coactivator of the estrogen receptor alpha, confers hypersensitivity to estrogen action.

Rakesh Kumar, S. Rayala, D. Coverley, 2006, Cancer research.

Commentary: targeting colorectal cancer through molecular biology.

Rakesh Kumar, Rakesh Kumar, 2005, Seminars in oncology.

Signaling-dependent and coordinated regulation of transcription, splicing, and translation resides in a single coregulator, PCBP1

Anupama E. Gururaj, Bert W O'Malley, B. O’Malley, 2007, Proceedings of the National Academy of Sciences.

A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid Tumors

Gopinath Ganji, J. Tolson, Shanker Kalyana-Sundaram, 2017, Clinical Cancer Research.

Transcriptomic landscape of breast cancers through mRNA sequencing

Liliana Florea, Prakriti Mudvari, S. Fuqua, 2012, Scientific Reports.

Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2.

Thomas Hartmann, Tom Boone, Juan Leal, 2004, Cancer cell.

The Global Cancer Genomics Consortium: interfacing genomics and cancer medicine.

Masakazu Toi, Sudeep Gupta, Stefan Knapp, 2012, Cancer research.

Demonstration of a genetic therapeutic index for tumors expressing oncogenic BRAF by the kinase inhibitor SB-590885.

Hieu T. Do, Meenhard Herlyn, David M. Wilson, 2006, Cancer research.

p21-activated kinases in cancer

Anupama E. Gururaj, Christopher J. Barnes, C. J. Barnes, 2006, Nature Reviews Cancer.

The role of Shc and insulin-like growth factor 1 receptor in mediating the translocation of estrogen receptor α to the plasma membrane

Christopher J. Barnes, C. J. Barnes, Yongde Bao, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Serine 88 Phosphorylation of the 8-kDa Dynein Light Chain 1 Is a Molecular Switch for Its Dimerization Status and Functions*

Jianpeng Ma, Jianpeng Ma, Mingjie Zhang, 2008, Journal of Biological Chemistry.

Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.

D. Chakravarty, P. R. Yew, S. Nair, 2010, Cancer research.

Pak protein kinases and their role in cancer

Jeffrey Field, K. Ohshiro, Rakesh Kumar, 2009, Cancer and Metastasis Reviews.

Nuclear p21-activated kinase 1 in breast cancer packs off tamoxifen sensitivity.

Rakesh Kumar, S. Rayala, P. Molli, 2006, Cancer research.

MicroRNA-7, a homeobox D10 target, inhibits p21-activated kinase 1 and regulates its functions.

K. Ohshiro, Rakesh Kumar, S. Rayala, 2008, Cancer research.

Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells.

Rakesh Kumar, P. den Hollander, Rakesh Kumar, 2006, Cancer research.

Deep sequencing of gastric carcinoma reveals somatic mutations relevant to personalized medicine

Joel S Parker, J. Parker, V. Weigman, 2011, Journal of Translational Medicine.

Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693

Emanuel F Petricoin, Dexter Pratt, E. Petricoin, 2010, BMC Genomics.

AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines.

Rakesh Kumar, J. Kahana, Rakesh Kumar, 2009, Blood.

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.

Yiling Lu, Lauren E Haydu, Gordon B Mills, 2017, Cell reports.

Differential regulation of components of the focal adhesion complex by heregulin: Role of phosphatase SHP‐2

Liana Adam, D. Nguyen, Rakesh Kumar, 2002, Journal of cellular physiology.

MTA1 promotes STAT3 transcription and pulmonary metastasis in breast cancer.

Yi Zheng, Prakriti Mudvari, Sandra Casimiro, 2013, Cancer research.

Vascular Endothelial Growth Factor Up-regulation via p21-activated Kinase-1 Signaling Regulates Heregulin-β1-mediated Angiogenesis*

John Mendelsohn, J. Mendelsohn, Rakesh Kumar, 2000, The Journal of Biological Chemistry.

Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity.

Robert A Copeland, Anthony E Choudhry, T. Gilmer, 2008, Cancer research.

Reflecting Back to Bring Nitric Oxide Research to the Laboratory.

Rakesh Kumar, Rakesh Kumar, 2016, Current medicinal chemistry.